Iterum Therapeutics plc (ITRMF) Long-Term Debt Repayments (2020 - 2025)

Iterum Therapeutics has reported Long-Term Debt Repayments for 4 years, with the latest figure at $14.7 million in Q1 2025.

• On a quarterly basis, Long-Term Debt Repayments changed N/A year-over-year to $14.7 million in Q1 2025; TTM through Sep 2025 was $14.7 million, a N/A change from a year earlier, with the FY2022 full-year figure at $2.3 million, down 65.45% from the prior year.
• Long-Term Debt Repayments was $14.7 million for Q1 2025 at Iterum Therapeutics, up from $2.3 million in the prior quarter.
• The five-year high for Long-Term Debt Repayments was $14.7 million in Q1 2025, with the low at $1.6 million in Q1 2021.
• Average Long-Term Debt Repayments over 3 years is $3.9 million, with a median of $1.6 million recorded in 2021.
• The sharpest annual moves came in 2021 and 2022: Long-Term Debt Repayments gained 3.23% in 2021, then surged 38.18% in 2022.
• Over 3 years, Long-Term Debt Repayments stood at $1.6 million in 2021, then soared by 38.18% to $2.3 million in 2022, then jumped by 555.04% to $14.7 million in 2025.
• The last three Long-Term Debt Repayments figures came in at $14.7 million (Q1 2025), $2.3 million (Q1 2022), and $1.6 million (Q4 2021), per Business Quant data.